Senti Biosciences, Inc.
NASDAQ: SNTI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Timothy K. Lu
- Employees
- 34
- Headquarters
- South San Francisco, United States
- IPO year
- 2021
- Market cap
- $28.4M
- Website
- https://www.sentibio.com
Loading SNTI…
Loading profile data…Frequently asked questions about SNTI
What does Senti Biosciences, Inc. (SNTI) do?
Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and r...
Where does SNTI trade?
Senti Biosciences, Inc. (SNTI) trades on the NASDAQ Global Market.
What sector is SNTI in?
Senti Biosciences, Inc. (SNTI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Senti Biosciences, Inc.?
Timothy K. Lu is the chief executive officer of Senti Biosciences, Inc. (SNTI).
Where is Senti Biosciences, Inc. headquartered?
Senti Biosciences, Inc. is headquartered in United States.
Does SNTI pay a dividend?
Senti Biosciences, Inc. (SNTI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNTI go public?
Senti Biosciences, Inc. (SNTI) completed its initial public offering in 2021.